Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced that its President and Chief Executive Officer, John P. Butler, will participate in the Jefferies Virtual Global Healthcare Conference on Tuesday, June 2 at 8:00 a.m. ET.
May 26, 2020
· 1 min read